Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucovorin for Young Children With Autism
NCT04060030Phase 2Recruiting
- Sponsor
- Southwest Autism Research & Resource Center
- Start
- Oct 2020
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of levoleucovorin in Autism Spectrum Disorder (ASD), language disorder, sponsored by Southwest Autism Research & Resource Center. Started Oct 2020; status: recruiting.
02
Drugs
levoleucovorin
03
Conditions
Autism Spectrum Disorder (ASD)language disorder
Beyond the preview
Go deeper on NCT04060030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060030.